Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

Development Status

US Previously Marketed

1

All Match

Any Match

Exclude Selected

Exclude Selected

Primary Target

Sulfonylurea receptor 2, Kir6.2

1

Transient receptor potential cation channel subfamily A member 1

1

All Match

Any Match

Exclude Selected

Exclude Selected

Highest Phase

Approved

1

All Match

Any Match

Exclude Selected

Exclude Selected

Approval Year

1989

1

All Match

Any Match

Exclude Selected

Exclude Selected

Condition

Hypertension

1

All Match

Any Match

Exclude Selected

Exclude Selected

Treatment Modality

Primary

1

All Match

Any Match

Exclude Selected

Exclude Selected

CNS Activity

CNS Non-penetrant

1

All Match

Any Match

Exclude Selected

Exclude Selected

Originator

Leo Pharma

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Class

Chemical

1

All Match

Any Match

Exclude Selected

Exclude Selected

Code System

CAS

1

ChEMBL

1

DRUG BANK

1

DRUG CENTRAL

1

EPA CompTox

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 1

CARDIOVASCULAR SYSTEM

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 2

ANTIHYPERTENSIVES

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 3

ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION

1

ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 4

Guanidine derivatives

1

Other antihypertensives and diuretics

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Form

Salts, Hydrates, Esters, etc.

1

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for "VATC|ANTIHYPERTENSIVES|ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON|Guanidine derivatives" in comments (approximate match)

Showing 1 - 1 of 1 results

First page disabled
Previous page disabled
1
Next page disabled
Next page disabled

PINACIDIL

7B0ZZH8P2W

Export Data
Search for Structure

Status:

US Previously Marketed

First approved in 1989

Class (Stereo):

CHEMICAL (RACEMIC)

Targets:

Sulfonylurea receptor 2, Kir6.2

Transient receptor potential cation channel subfamily A member 1

Conditions:

Pinacidil is a clinically effective vasodilator used for the treatment of hypertension.

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1